title: Is there a time limit for systemic menopausal hormone therapy?
abstract: In deciding whether it is time to stop hormone therapy, in addition to the patient's age we need to consider her preferences, symptoms, quality of life, time since menopause, hysterectomy status, and personal risks of osteoporosis, breast cancer, heart disease, stroke, and venous thromboembolism. This article presents the evidence for and against extending hormone therapy and a guide for making this highly individualized and shared decision.
authors: Director, Primary Care Women's Health, Medicine Institute, Cleveland Clinic Beachwood Family Health Center, Beachwood, OH, USA. E-mail: dorrl@ccf.org.|Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
authors: Laura Dorr
authors: LD
authors: Lipold
authors: Education Director, Primary Care Women's Health, Department of Community Internal Medicine, Cleveland Clinic, Independence, OH, USA.|Deputy Editor, Cleveland Clinic Journal of Medicine, Lyndhurst, OH, USA.|Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
authors: Pelin
authors: P
authors: Batur
authors: Clinical Professor, University of California, San Francisco, CA, USA.
authors: Risa
authors: R
authors: Kagan
mesh_terms: D015914:Estrogen Replacement Therapy / Q000379:methods*; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D018570:Risk Assessment / Q000379:methods*; D013997:Time Factors; D028761:Withholding Treatment / Q000592:standards*
chemical_list: D004967:Estrogens